SCHEMBL37941

SCHEMBL37941

Clc1cccc(Cl)c1-c1c2nc(c(-c3c(Cl)cccc3Cl)c3ccc([nH]3)c(-c3c(Cl)cccc3Cl)c3nc(c(-c4c(Cl)cccc4Cl)c4ccc1[nH]4)C=C3)C=C2

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 4/20 0.45
▸ TOP1 P11387 2/20 0.44
▸ CYCS P99999 2/20 0.42
▸ ENPP2 Q13822 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29693613 1.00 TERT (0.45) TERTTOP1CYCSENPP2
Magnesium SCHEMBL30497533 0.98 TERT (0.44) TERTTOP1CYCSENPP2
SCHEMBL29437843 0.98 TERT (0.44) TERTTOP1CYCSENPP2
SCHEMBL28349025 0.98 TERT (0.44) TERTTOP1CYCSENPP2
SCHEMBL29472186 0.98 TERT (0.44) TERTTOP1CYCSENPP2
SCHEMBL28507436 0.98 TERT (0.44) TERTTOP1CYCSENPP2
SCHEMBL28365832 0.98 TERT (0.44) TERTTOP1CYCSENPP2
SCHEMBL7156525 0.95 TERT (0.41) TERTTOP1CYCSENPP2
SCHEMBL30644786 0.90 TERT (0.39) TERTTOP1CYCSENPP2
SCHEMBL30644753 0.90 TERT (0.39) TERTTOP1CYCSENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260048152-A1 GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES KARLSRUHER INSTITUT FUER TECH KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) 2026-02-19 — — US claimed
US-12145951-B2 Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) 2024-11-19 — — US claimed
US-20210292353-A1 INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2021-09-23 — — US claimed
EP-3829565-A1 INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE Karlsruher Institut für Technologie (DE) 2021-06-09 — — EP claimed
US-10610472-B2 High energy visible light filter systems with yellowness index values HIGH PERFORMANCE OPTICS, INC. (US) 2020-04-07 — — US claimed
WO-2020025488-A1 INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE Karlsruher Institut für Technologie (DE) 2020-02-06 — — WO claimed
US-10420471-B2 Method of deep tissue imaging using multi-photon excitation of a fluorophore RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2019-09-24 — — US claimed
US-20180064616-A1 High Energy Visible Light Filter Systems with Yellowness Index Values HIGH PERFORMANCE OPTICS, INC. (US) 2018-03-08 — — US claimed
US-9814658-B2 High energy visible light filter systems with yellowness index values HIGH PERFORMANCE OPTICS, INC. (US) 2017-11-14 — — US claimed
US-20170112948-A1 Inorganic-organic hybrid compound Karlsruher Institut für Technologie (DE) 2017-04-27 — — US claimed
EP-2602654-A1 Ophthalmic filter Essilor International (Compagnie Générale D'Optique) (FR) 2013-06-12 — — EP claimed
EP-2591396-A1 HIGH ENERGY VISIBLE LIGHT FILTER SYSTEMS WITH YELLOWNESS INDEX VALUES High Performance Optics, Inc. (US) 2013-05-15 — — EP claimed
EP-1841739-B1 PROCESS FOR PRODUCING 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL] PIPERIDINE OR SALT THEREOF VIA NOVEL INTERMEDIATE JUBILANT ORGANOSYS LTD (IN) 2013-02-20 — — EP claimed
WO-2012006265-A1 HIGH ENERGY VISIBLE LIGHT FILTER SYSTEMS WITH YELLOWNESS INDEX VALUES HIGH PERFORMANCE OPTICS, INC. (US) 2012-01-12 — — WO claimed
US-20120008217-A1 High Energy Visible Light Filter Systems with Yellowness Index Values HIGH PERFORMANCE OPTICS, INC. (US) 2012-01-12 — — US claimed
US-20110198538-A1 INORGANIC-ORGANIC COMPOSITE LUMINOPHORE Karlsruher Institut for Technologie (KIT) (DE) 2011-08-18 — — US claimed
EP-2179006-A1 INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE Karlsruher Institut für Technologie (DE) 2010-04-28 — — EP claimed
WO-2009100800-A1 INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE UNIVERSITÄT KARLSRUHE (TH) (DE) 2009-08-20 — — WO claimed
EP-0705821-A1 Oxidation of nitrogen heterocycles and heterocyclic N-oxides produced thereby SOLVAY INTEROX (Société Anonyme) (BE) 1996-04-10 — — EP claimed
US-5103027-A Catalyst selectivity ARCO CHEMICAL TECHNOLOGY, L.P. (US) 1992-04-07 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260048152-A1 GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES GOT1, RNMT, GNAO1 TERT 589/4885TOP1 261/4885CYCS 3912/4885
US-20170112948-A1 Inorganic-organic hybrid compound SLCO4C1, SLCO2A1, SLCO1A2 TERT 878/4885TOP1 3915/4885CYCS 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback